These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 8757358)

  • 1. Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients.
    Koo J; Tight R; Rajkumar V; Hawa Z
    Am J Med; 1996 Aug; 101(2):177-83. PubMed ID: 8757358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
    Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y
    Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of once- versus thrice-daily tobramycin in febrile neutropenic children undergoing stem cell transplantation.
    Sung L; Dupuis LL; Bliss B; Taddio A; Abdolell M; Allen U; Rolland M; Tong A; Taylor T; Doyle J
    J Natl Cancer Inst; 2003 Dec; 95(24):1869-77. PubMed ID: 14679156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial pharmacokinetic dosing of aminoglycosides: a community hospital experience.
    Hoffa DE
    Ther Drug Monit; 1989 Sep; 11(5):574-9. PubMed ID: 2815234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, controlled trial comparing once daily and three times daily gentamicin in children with urinary tract infections.
    Carapetis JR; Jaquiery AL; Buttery JP; Starr M; Cranswick NE; Kohn S; Hogg GG; Woods S; Grimwood K
    Pediatr Infect Dis J; 2001 Mar; 20(3):240-6. PubMed ID: 11303823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation and nephrotoxicity of a simplified once-daily aminoglycoside dosing schedule and guidelines for monitoring therapy.
    Prins JM; Weverling GJ; de Blok K; van Ketel RJ; Speelman P
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2494-9. PubMed ID: 8913452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.
    Prescott WA; Nagel JL
    Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
    Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
    J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the evidence for once-daily aminoglycoside therapy?
    Barclay ML; Begg EJ; Hickling KG
    Clin Pharmacokinet; 1994 Jul; 27(1):32-48. PubMed ID: 7955770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
    Prescott WA
    Respir Care; 2014 Sep; 59(9):1353-9. PubMed ID: 24782555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-daily versus multiple-daily dosing of aminoglycosides.
    Craig WA
    J Chemother; 1995 Jun; 7 Suppl 2():47-52. PubMed ID: 8622110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of gentamicin and tobramycin nephrotoxicity in patients receiving individualized-pharmacokinetic dosing regimens.
    Pancorbo S; Compty C; Heissler J
    Biopharm Drug Dispos; 1982; 3(1):83-8. PubMed ID: 7082782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens.
    Barletta JF; Johnson SB; Nix DE; Nix LC; Erstad BL
    J Trauma; 2000 Nov; 49(5):869-72. PubMed ID: 11086778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-daily aminoglycoside dosing: An update on current literature.
    Stankowicz MS; Ibrahim J; Brown DL
    Am J Health Syst Pharm; 2015 Aug; 72(16):1357-64. PubMed ID: 26246292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of once-daily dosing of aminoglycosides through Bayesian simulation.
    Garrelts JC
    Pharmacotherapy; 1996; 16(2):286-94. PubMed ID: 8820474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring of tobramycin: once-daily versus twice-daily dosage schedules.
    Sánchez-Alcaraz A; Vargas A; Quintana MB; Rocher A; Querol JM; Poveda JL; Hermenegildo M
    J Clin Pharm Ther; 1998 Oct; 23(5):367-73. PubMed ID: 9875685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily gentamicin dosing in pediatric patients without cystic fibrosis.
    McDade EJ; Wagner JL; Moffett BS; Palazzi DL
    Pharmacotherapy; 2010 Mar; 30(3):248-53. PubMed ID: 20180608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can pharmacokinetic dosing decrease nephrotoxicity associated with aminoglycoside therapy.
    Leehey DJ; Braun BI; Tholl DA; Chung LS; Gross CA; Roback JA; Lentino JR
    J Am Soc Nephrol; 1993 Jul; 4(1):81-90. PubMed ID: 8400072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.